NTHI — NEONC TECHNOLOGIES HOLDINGS, INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1979414 ·
Last close
$4.81
Market Cap
$124.74M
52W High
$9.00
52W Low
$3.87
ADV30
94,884
Next earnings
2026-08-14
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -7,008,539 | -8,819,932 | 3,330,161 | 138,601 | 16,561,326 |
| Dec 2025 | 0 | — | -13,625,675 | -15,524,104 | 2,823,634 | 58,729 | 20,331,363 |
| Sep 2025 | 0 | — | -6,934,647 | -8,615,920 | 4,082,916 | 1,513,224 | 15,897,186 |
| Jun 2025 | 0 | — | -5,708,034 | -5,680,170 | 2,988,187 | 125,039 | 14,803,681 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-21,705,667
Investing CF
—
Financing CF
$16,905,056
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.91
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-121,574,587
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-35,461,857
Pretax Income TTM
$-38,640,126
Interest Exp TTM
$3,178,269
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$0
EBITDA
—
Free Cash Flow
$-1,603,043
Enterprise Value
$131,345,192
Total Cash
$138,601
Total Debt
$346,053
Shares Out
25,933,365
Trailing EPS
$-1.80
Book Value
$-0.55
ROE
—
ROA
-354.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 39,990 | -58,169,198 | -62,146,210 | 2,823,634 | 20,331,363 | — | -20,363,948 |
| Dec 2024 | 83,000 | -7,142,522 | -11,898,464 | 3,417,241 | 8,922,202 | — | -4,213,916 |
| Dec 2023 | 70,462 | -8,097,669 | -14,921,065 | 1,265,376 | 15,253,629 | — | -1,880,012 |
| Dec 2022 | 20,000 | -2,837,604 | -3,046,757 | 728,682 | 2,304,093 | — | -881,736 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.75
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SPRO | Spero Therapeutics, Inc. | $122.17M | $2.11 | — |
| DERM | Journey Medical Corp | $127.48M | $5.92 | — |
| MSLE | Satellos Bioscience Inc. | $121.86M | $5.85 | — |
| GNLX | GENELUX Corp | $127.80M | $2.85 | — |
| LIXT | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | $121.01M | $6.96 | — |
News headlines (Yahoo Finance, 1h cache)
NeOnc Technologies Secures UAE IND Approval for NEO212 Following Successful Phase 1 Completion, Advancing Toward Global Phase 2 Development
2026-06-16 14:03 · Yahoo
WSTPR Catalyst Watch: NeOnc Strengthens Capital Position Ahead of Potentially Transformational Neuro-Oncology Updates
2026-06-15 12:35 · Yahoo
The Race to Defeat Brain Cancer Could Become One of the Biggest Biotech Stories of the Decade
2026-06-09 12:45 · Yahoo
NeOnc Technologies (NTHI) Could Be Targeting A Challenging Market With A Different Strategy
2026-05-31 14:38 · Yahoo
NeOnc Provides Business Update and Reports Q1 2026 Financial Results
2026-05-18 13:00 · Yahoo
Forget the 242% Biotech Meme. This Brain Cancer Stock Has a $38 Analyst Target and Trades at $6
2026-05-14 15:39 · Yahoo
NeOnc CEO Accelerates Insider Buying with $500K+ Investment Ahead of Imminent NEO100 Phase 2a Data Catalysts
2026-05-05 13:00 · Yahoo
New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings (NASDAQ:VTIX), Neonc Technologies Holdings (NASDAQ:NTHI), Medicus Pharma (NASDAQ:MDCX), YY Gro
2026-04-18 14:00 · Yahoo
NeOnc Technologies Holdings, Inc. Announces ~ $300,000 in Insider Purchases of NTHI Stock by Chairman and CEO; Company Provides Context on 2025 Financial Results
2026-04-14 13:00 · Yahoo
NeOnc Provides Business Update and Reports Q4 2025 Financial Results
2026-04-01 13:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.